Literature DB >> 20155824

Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.

Alfiya Akhmetshina1, Jürgen Beer, Karin Zwerina, Matthias Englbrecht, Katrin Palumbo, Clara Dees, Nicole Reich, Jochen Zwerina, Gabriella Szucs, Johannes Gusinde, Tatiana Nevskaya, Oliver Distler, Dontscho Kerjaschki, Georg Schett, Jörg H W Distler.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a connective tissue disease that is characterized by microvascular disease and tissue fibrosis. Progressive loss and irregular architecture of the small blood vessels are well characterized, but the potential involvement of the lymphatic vessel system has not been analyzed directly in SSc. This study was undertaken to assess whether the lymphatic vascular system is affected in SSc, and whether changes to the lymphatic vessels are associated with dystrophic changes and tissue damage in patients with SSc.
METHODS: Lymphatic endothelial cells in skin biopsy samples from patients with SSc and age- and sex-matched healthy volunteers were identified by staining for podoplanin and prox-1, both of which are specifically expressed in lymphatic endothelial cells but not in blood vascular endothelial cells. CD31 was used as a pan-endothelial cell marker. Statistical analyses were performed using Kruskal-Wallis, Mann-Whitney U, and Spearman's rank correlation tests.
RESULTS: The numbers of podoplanin- and prox-1-positive lymphatic vessels were significantly reduced in patients with SSc as compared with healthy individuals. The number of podoplanin-positive lymphatic precollector vessels was significantly lower in SSc patients with fingertip ulcers than in SSc patients without ulcers. Moreover, the number of lymphatic vessels correlated inversely with the number of fingertip ulcers at the time of biopsy and with the number of fingertip ulcers per year. The inverse correlation between lymphatic precollector vessel counts and fingertip ulcers remained significant after statistical adjustment for the blood vessel count, age, and modified Rodnan skin thickness score.
CONCLUSION: These results demonstrate a severe reduction in the number of lymphatic capillaries and lymphatic precollector vessels in patients with SSc. Patients with decreased lymphatic vessel counts may be at particularly high risk of developing fingertip ulcers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155824     DOI: 10.1002/art.27406

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases.

Authors:  Radjesh Bisoendial; Erik Lubberts
Journal:  Mediators Inflamm       Date:  2022-05-17       Impact factor: 4.529

2.  Lymphedema secondary to limited cutaneous systemic sclerosis.

Authors:  Sónia Moreira; Jorge Crespo; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2018-06-15

3.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

4.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 5.  Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities.

Authors:  Tomoaki Iwayama; Lorin E Olson
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

6.  Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.

Authors:  Katrin G Schmidt; Martina Herrero San Juan; Sandra Trautmann; Lucija Berninger; Anja Schwiebs; Florian M Ottenlinger; Dominique Thomas; Frank Zaucke; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 7.  Lymphatic Function in Autoimmune Diseases.

Authors:  Noa Schwartz; Madhavi Latha S Chalasani; Thomas M Li; Zhonghui Feng; William D Shipman; Theresa T Lu
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

8.  Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.

Authors:  Mirko Manetti; Eloisa Romano; Irene Rosa; Bianca Saveria Fioretto; Serena Guiducci; Silvia Bellando-Randone; Erika Pigatto; Franco Cozzi; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

9.  Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.

Authors:  Marilisa Villano; Annalisa Borghini; Mirko Manetti; Erica Gabbrielli; Antonella Rossi; Piersante Sestini; Anna Milia; Francesca Nacci; Serena Guiducci; Marco Matucci-Cerinic; Lidia Ibba-Manneschi; Elisabetta Weber
Journal:  Arthritis Res Ther       Date:  2013-08-20       Impact factor: 5.156

Review 10.  Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Authors:  Cosimo Bruni; Tracy Frech; Mirko Manetti; Francesca Wanda Rossi; Daniel E Furst; Amato De Paulis; Felice Rivellese; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.